Identification of she Src homology 2 domain-binding peptoid-peptide hybrids

Journal of Medicinal Chemistry

Volumn 52, Issue 6, 2009, Pages 1612-1618

  Choi, Won Jun ^a   Kim, Sung Eun ^a   Stephen, Andrew G ^b   Weidlich, Iwona ^a,c   Giubellino, Alessio ^a   Liu, Fa ^a   Worthy, Karen M ^b   Bindu, Lakshman ^b   Fivash, Matthew J ^d   Nicklaus, Marc C ^a   Bottaro, Donald P ^a   Fisher, Robert J ^b   Burke Jr , Terrence R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALKENYL GROUP; AMIDE; FLUORESCEIN ISOTHIOCYANATE; GLYCINE; HYBRID PROTEIN; PEPTIDE; PEPTOID; PROTEIN SHC; PROTEIN TYROSINE KINASE; RON PROTEIN;

ANISOTROPY; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; FLUORESCENCE; IC 50; PROTEIN BINDING; PROTEIN DOMAIN; RING CLOSING METATHESIS; SEQUENCE HOMOLOGY; SUBSTITUTION REACTION; AMINO ACID SEQUENCE; CHEMISTRY; FLUORESCENCE POLARIZATION; MASS SPECTROMETRY; METABOLISM; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SRC HOMOLOGY DOMAIN;

AMINO ACID SEQUENCE; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENCE POLARIZATION; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR SEQUENCE DATA; PEPTIDES; PEPTOIDS; RECEPTOR PROTEIN-TYROSINE KINASES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SRC HOMOLOGY DOMAINS;

EID: 64349118039     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm800789h     Document Type: Article

References (30)

1. Wells, J. A.; McClendon, C. L. Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 2007, 450, 1001-1009.
2. Bradshaw, J. M.; Waksman, G. Molecular recognition by SH2 domains. Adv. Protein Chem. 2003, 61, 161-210.
3. Pawson, T. Specificity in signal transduction: from phosphotyrosine- SH2 domain interactions to complex cellular systems. Cell 2004, 116, 191-203.
4. Pawson, T.; Gish, G. D.; Nash, P. The SH2 domain: a prototype for protein interaction modules. Modular Protein Domains 2005, 5-36.
5. Ladbury, J. E. Protein-protein recognition in phosphotyrosine-mediated intracellular signaling. Protein Rev. 2005, 3, 165-184.
6. Machida, K.; Mayer, B. J. The SH2 domain: versatile signaling module and pharmaceutical target. Biochim. Biophys. Acta, Proteins Proteom-ics 2005, 1747, 1-25.
7. Broadbridge, R. J.; Sharma, R. P. The Src homology-2 domains (SH2 domains) of the protein tyrosine kinase p56lck: structure, mechanism and drug design. Curr. Drug Targets 2000, 1, 365-386.
8. Shakespeare, W. C. SH2 domain inhibition: a problem solved. Curr. Opin. Chem. Biol. 2001, 5, 409-415.
9. Metcalf, C. A., III; Sawyer, T. Src homology-2 domains and structure- based, small-molecule library approaches to drug discovery. Drug Discovery Strategies Methods 2004, 23-59.
10. Garcia-Echeverria, C. Inhibitors of signaling interfaces: targeting Src homology 2 domains in drug discovery. Protein Tyrosine Kinases 2006, 31-52.
11. Burke, T. R., Jr. Development of Grb2 SH2 domain signaling antagonists: a potential new class of antiproliferative agents. Int. J. Pept. Res. Ther. 2006, 12, 33-48.
12. Batzer, A. G.; Rotin, D.; Urena, J. M.; Skolnik, E. Y.; Schlessinger, J. Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor. Mol. Cell. Biol. 1994, 14, 5192-201.
13. Zhou, M. M.; Harlan, J. E.; Wade, W. S.; Crosby, S.; Ravichandran, K. S.; Burakoff, S. J.; Fesik, S. W. Binding affinities of tyrosine- phosphorylated peptides to the COOH-terminal SH2 and NH2-terminal phosphotyrosine binding domains of Shc. J. Biol. Chem. 1995, 270, 31119-31123.
14. Pelicci, G.; Lanfrancone, L.; Grignani, F.; McGlade, J.; Cavallo, F.; Forni, G.; Nicoletti, I.; Grignani, F.; Pawson, T.; Pelicci, P. G. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 1992, 70, 93-104.
15. Ravichandran, K. S. Signaling via Shc family adapter proteins. Oncogene 2001, 20, 6322-6330.
16. Saucier, C.; Khoury, H.; Lai, K. M. V.; Peschard, P.; Dankort, D.; Naujokas, M. A.; Holash, J.; Yancopoulos, G. D.; Muller, W. J.; Pawson, T.; Park, M. The Shc adaptor protein is critical for VEGF induction by Met/HGF and ErbB2 receptors and for early onset of tumor angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 2345-2350.
17. Saucier, C.; Papavasiliou, V.; Palazzo, A.; Naujokas, M. A.; Kremer, R.; Park, M. Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis. Oncogene 2002, 21, 1800-1811.
18. Ursini-Siegel, J.; Hardy, W. R.; Zuo, D.; Lam, S. H. L.; Sanguin-Gendreau, V.; Cardiff, R. D.; Pawson, T.; Muller, W. J. ShcA signalling is essential for tumour progression in mouse models of human breast cancer. EMBO J. 2008, 27, 910-920.
19. Zhou, M.-M.; Meadows, R. P.; Logan, T. M.; Yoon, H. S.; Wade, W. S.; Ravichandran, K. S.; Burakoff, S. J.; Fesik, S. W. Solution structure of the Shc SH2 domain complexed with a tyrosine-phosphorylated peptide from the T-cell receptor. Proc. Natl. Acad. Sci. U.S.A. 1995, 92 (17), 7784-7788.
20. Protein Data Bank code 1TCE.
21. See Novabiochem Letters, January 2004 (catalog number 04-12-3911).
22. Kertesz, A.; Varadi, G.; Toth, G. K.; Fajka-Boja, R.; Monostori, E.; Sarmay, G. Optimization of the cellular import of functionally active SH2-domain-interacting phosphopeptides. Cell. Mol. Life Sci. 2006, 63, 2682-2693.
23. Garcia-Echeverria, C.; Jiang, L.; Ramsey, T. M.; Sharma, S. K.; Chen, Y. N. P. A new Antennapedia-derived vector for intracellular delivery of exogenous compounds. Bioorg. Med. Chem. Lett. 2001, 11, 1363-1366.
24. Blackwell, H. E.; Sadowsky, J. D.; Howard, R. J.; Sampson, J. N.; Chao, J. A.; Steinmetz, W. E.; O'Leary, D. J.; Grubbs, R. H. Ring- closing metathesis of olefinic peptides: design, synthesis, and structural characterization of macrocyclic helical peptides. J. Org. Chem. 2001, 66, 5291-5302.
25. Oishi, S.; Shi, Z.-D.; Worthy, K. M.; Bindu, L. K.; Fisher, R. J.; Burke, T. R., Jr. Ring-closing metathesis of allylglycines with β-vinyl- substituted residues as an approach to novel macrocyclic β-bend mimetics. ChemBioChem 2005, 6, 668-674.
26. Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Synthesis and activity of a new generation of ruthenium-based olefin metathesis catalysts coordinated with 1,3-dimesityl-4,5 dihydroimidazol-2-ylidene ligands. Org. Lett. 1999, 1, 953-956.
27. Mikol, V.; Baumann, G.; Zurini, M. G. M.; Hommel, U. Crystal structure of the SH2 domain from the adaptor protein SHC: a model for peptide binding based on X-ray and NMR data. J. Mol. Biol. 1995, 254, 86-95.
28. Oishi, S.; Karki, R. G.; Shi, Z.-D.; Worthy, K. M.; Bindu, L.; Chertov, O.; Esposito, D.; Frank, P.; Gillette, W. K.; Maderia, M.; Hartley, J.; Nicklaus, M. C.; Barchi, J. J., Jr.; Fisher, R. J.; Burke, T. R., Jr. Evaluation of macrocyclic Grb2 SH2 domain-binding peptide mimetics prepared by ring-closing metathesis of C-terminal allylglycines with an N-terminal beta-vinyl-substituted phosphotyrosyl mimetic. Bioorg. Med. Chem. 2005, 13, 2431-2438.
29. Lakowicz, J. R. Principles of Fluorescence Spectroscopy, 2nd ed.; Kluwer Academic/Plenum Publishers: New York, 1999.
30. Boor, C. D. Principles of Fluorescence Spectroscopy, 2nd ed.; Kluwer Academic/Plenum Publishers: New York, 1999.